BILIARY HAMARTOMA

BILIARY HAMARTOMA was reported 19 times

BILIARY HAMARTOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 1 0.0002
1 Antimetabolite Immunosuppressant [EPC] 2 0.0001
2 Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] 1 0.0001
3 Calcineurin Inhibitor Immunosuppressant [EPC] 7 0.0001
4 Vitamin D3 Analog [EPC] 1 0.0000
5 Radiographic Contrast Agent [EPC] 1 0.0000
6 Androgen [EPC] 1 0.0000
7 Estrogen Receptor Antagonist [EPC] 1 0.0000
8 Aminoglycoside Antibacterial [EPC] 1 0.0000
9 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
10 Macrolide Antimicrobial [EPC] 1 0.0000
11 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
12 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
13 Calcium [EPC] 1 0.0000
14 Insulin Analog [EPC] 3 0.0000
15 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
16 Corticosteroid [EPC] 8 0.0000
17 RANK Ligand Inhibitor [EPC] 1 0.0000
18 Thiazide Diuretic [EPC] 1 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
20 Factor Xa Inhibitor [EPC] 1 0.0000
21 Osmotic Laxative [EPC] 1 0.0000
22 Benzodiazepine [EPC] 2 0.0000
23 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
24 Vitamin C [EPC] 1 0.0000
25 Atypical Antipsychotic [EPC] 1 0.0000
26 Loop Diuretic [EPC] 1 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
28 Kinase Inhibitor [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 1 0.0000
30 Proton Pump Inhibitor [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000